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IL-4 driven transcription factor 
FoxQ1 is expressed by monocytes 
in atopic dermatitis and stimulates 
monocyte migration
Ilja Ovsiy1, Vladimir Riabov1,2, Ioannis Manousaridis1, Julia Michel2, Kondaiah Moganti2, 
Shuiping Yin2, Tengfei Liu2, Carsten Sticht3, Elisabeth Kremmer4, Martin C. Harmsen5,  
Sergij Goerdt1, Alexei Gratchev1,6 & Julia Kzhyshkowska1,2,7
Monocytes are actively recruited at sites of chronic inflammation. However, molecular factors involved 
in this process are not fully elucidated. Here, we show that cytokine IL-4 which is implicated in the 
development of chronic inflammatory disease atopic dermatitis (AD) induces expression of transcription 
factor FoxQ1 in human monocytes and macrophages. FoxQ1 mRNA levels were elevated in monocytes 
of AD patients compared to healthy donors. Overexpression of FoxQ1 in RAW 264.7 monocytic cells 
facilitated their migration towards MCP-1 and was associated with decreased expression of migration-
regulating genes (claudin 11 and plexin C1). Furthermore, FoxQ1 overexpression in RAW cells 
accelerated TNFα secretion after LPS challenge. Overall, our results indicate that FoxQ1 stimulates 
monocyte motility, increases pro-inflammatory potential, and directs monocyte migration towards 
MCP-1 that is crucial for monocyte influx into inflammatory sites. This mechanism could contribute to 
the pathogenesis of chronic inflammatory disorders such as AD.
Monocytes are critical components of inflammatory reactions. Increased numbers of infiltrating monocytes is 
characteristic for acute and chronic inflammatory disorders including atherosclerosis, chronic liver diseases, and 
atopic dermatitis (AD)1–3. Damaged and inflamed tissue attracts and recruits circulating monocytes by secret-
ing MCP-1. This key monocyte recruiting chemokine is secreted by various cell types including epithelial cells, 
fibroblasts, endothelial cells and monocytes3,4. At the site of inflammation, monocytes differentiate into mature 
macrophages under control of local tissue-derived and inflammatory factors. In case of an acute inflammatory 
response to pathogens or trauma, monocyte-derived macrophages exert their anti-bacterial function, clear the 
infection, and stimulate the resolution of inflammation and healing. The inability of macrophages to control 
the resolution phase results in development of chronic inflammation. The balance of cytokines and chemokines 
produced by macrophages, T-cells and other immune cells is critical for efficient resolution of inflammation. Key 
prototype cytokines involved in the regulation of acute inflammation and its resolution are IFN-γ and IL-4. IFN-γ 
induces acute phase of inflammation and is recognized as prototypic M1-polarizing factor5. IL-4 antagonizes 
effects of IFN-γ and stimulates alternative macrophage activation which is associated with extracellular matrix 
remodeling, repair and resolution of inflammation5,6. However, increased systemic and local IL-4 levels are also 
found in chronic Th2-associated inflammatory conditions such as asthma and AD7–10. AD is a chronic inflam-
matory skin disease which is characterized by abnormalities in skin barrier function (itchy, red, swollen skin), 
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and immune dysregulation10,11. In AD immune dysregulation involves increased infiltration of IL-4-producing 
Th2 cells, eosinophils and macrophages expressing elevated levels of the scavenger receptor CD163 and mannose 
receptor (CD206)2,12,13. Recently, forkhead box transcription factor FoxQ1 has been identified as one of the hubs 
in IL-4 activated transcriptional networks in human macrophages14. However, despite involvement of FoxQ1 in 
migration, invasion and proliferation of tumor cells, its functional role in monocytes/macrophages and associa-
tion with human pathologies other than cancer remained unknown15–18.
In this study we demonstrate that FoxQ1 expression is upregulated in circulating monocytes of patients 
with AD. Utilizing ex vivo cultured monocyte-derived macrophages from healthy donors we revealed stringent 
regulation of FoxQ1 expression by Th1/Th2-associated cytokines. Using gain-of function approach we demon-
strated that FoxQ1 markedly enhances migration of monocytes towards chemokine MCP-1. By analyzing 
FoxQ1-regulated genes we revealed that both activation of cytoskeleton dynamics and suppression of negative 
regulator of migration Plexin C1 are associated with FoxQ1-inducible migration. Overall, our results indicate 
that FoxQ1 is critical factor for IL-4-mediated recruitment of monocytes in chronic inflammatory conditions.
Results
FoxQ1 expression in macrophages is stimulated by IL-4 and suppressed by IFN-γ. Recently, 
the Th2-associated cytokine IL-4 was shown to enhance expression of FoxQ1 in human monocyte-derived mac-
rophages14. However, the regulation of its expression by Th1/Th2 cytokine balance was not studied. It was pre-
viously found in our laboratory that macrophages induced by IL-4 are plastic cells, and can be reprogrammed 
in culture conditions19. Therefore, the regulation of FoxQ1 expression was analyzed in macrophages upon their 
reprogramming by cytokines and bacterial products. Monocytes isolated from buffy coats were cultured with-
out stimulation or in the presence of IL-4 or IFN-γ. On the sixth day of culture the cells were restimulated with 
IFN-γ or LPS for 6 h and FoxQ1 expression was analysed using RT-qPCR. Indeed, IL-4 stimulation for 6 days 
significantly increased FoxQ1 expression in macrophages (p < 0.001) whereas its expression was negligible in 
non-stimulated and IFN-γ-stimulated macrophages (Fig. 1A). Re-stimulation of IL-4-treated macrophages with 
IFN-γ or LPS resulted in rapid downregulation of FoxQ1 mRNA expression indicating stringent regulation by 
Th1/Th2 cytokines and bacterial products (Fig. 1A). We further examined the dynamics of FoxQ1 expression in 
response to IL-4 stimulation using monocytes from 5 healthy donors. Increased expression of FoxQ1 gene was 
evident already 3 h after addition of IL-4 and rapidly increased between 6 h and 25 h of stimulation indicating 
direct and tight regulation of FoxQ1 expression by IL-4 (Fig. 1B and Supplementary Fig. 1).
On the protein level FoxQ1 was weakly expressed in non-stimulated macrophages (ns) and more pronounc-
edly in IL-4 stimulated monocyte-derived macrophages as detected by immunofluorescent staining/confocal 
microscopy on day 6 of culture (Fig. 2). The pattern of protein expression revealed preferential nuclear locali-
zation of FoxQ1 in human primary macrophages (Fig. 2). However, in contrast to human colorectal cancer cell 
line WIDR that was used as a positive control and showed nearly exclusive nuclear localization of FoxQ1, in 
macrophages its expression was also detectable in the cytoplasm (Fig. 2 and Supplementary Fig. 2)
FoxQ1 expression is enhanced in monocytes of AD patients. Increased IL-4 expression is found 
during chronic inflammatory conditions (e.g. asthma, allergic inflammation and AD) that are also character-
ized by increased influx of monocytes/macrophages to the lesions8,20,21. Since IL-4 plays an important role in 
the pathogenesis of atopic dermatitis (AD), we further tested whether expression of FoxQ1 is changed in blood 
monocytes from AD patients compared to healthy donors. The analysis revealed significant increase in expression 
of FoxQ1 in monocytes of AD patients compared to healthy donors (p = 0.0016) suggesting potential implication 
of FoxQ1 in pathogenesis of AD (Fig. 3).
Figure 1. The analysis of FoxQ1 mRNA expression in primary human macrophages. (A) Macrophages of 
8 healthy donors were stimulated with IL-4 or left non-stimulated (ns) for 6 days and then re-stimulated 
with IFN-γ or LPS for 6 hours. FoxQ1 expression was assessed using RT-qPCR. The data are mean ± SD. 
***p < 0.001, one-way ANOVA with Tukey’s multiple comparison test. (B) The dynamics of FoxQ1 mRNA 
expression was studied in IL-4-stimulated monocytes isolated from 6 healthy donors using RT-qPCR.
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FoxQ1 expression accelerates TNFα production but does not affect scavenging activities of 
RAW 264.7 cells. To study functional role of FoxQ1 in monocytes we generated murine monocyte/mac-
rophage RAW 264.7 clones stably expressing FoxQ1 (Supplementary Fig. 3). This monocyte cell line was selected 
due to negligible levels of endogenous FoxQ1 expression (data not shown). First, we have studied whether 
basic macrophage activities (inflammatory response, phagocytosis, and endocytosis) are affected by FoxQ1 
overexpression.
To assess inflammatory response, RAW-FoxQ1 cells and RAW-vector cells were stimulated by LPS, and pro-
duction of TNFα was quantified by ELISA 3 h, 6 h and 24 h after LPS challenge. Presence of FoxQ1 resulted in 
significant acceleration of TNFα secretion 3 h (p < 0.001) and 6 h (p < 0.05) after LPS stimulation indicating 
that FoxQ1 increases pro-inflammatory potential of monocytes/macrophages (Fig. 4A). TNFα production in 
unstimulated RAW-vector and RAW-FoxQ1 cells was below detection levels. In contrast, macrophage scavenging 
activity was not affected by FoxQ1 (Fig. 4B and C). Specifically, flow cytometry analysis of phagocytosis of fluores-
cent latex beads demonstrated that the presence of FoxQ1 had no effect on the phagocytic uptake in macrophages 
(Fig. 4B). Endocytosis is another essential macrophage function related to the resolution of inflammation and 
tissue remodeling22. Thus, we have compared endocytic uptake of fluorescently labeled acetylated low density 
Figure 2. The analysis of FoxQ1 protein expression in primary human macrophages. Monocytes were isolated 
from blood of healthy donors (n = 3) and cultured for 6 days without stimulation (ns) or in the presence of IL-4. 
FoxQ1 expression (red) was assessed by immunofluorescent staining/confocal microscopy using goat anti-
human FoxQ1 abs. Nuclei were visualized using DRAQ5 (blue). White arrows indicate cytoplasmic presence of 
FoxQ1 in macrophages. Representative images are shown. Scale bars: 10 µm.
Figure 3. RT-qPCR analysis of FoxQ1 mRNA expression in patients with atopic dermatitis. Monocytes were 
isolated from blood of patients with AD (n = 8) and healthy donors (n = 9) and directly used for RNA isolation. 
**p = 0.0016, Mann-Whitney U test.
www.nature.com/scientificreports/
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lipoprotein (acLDL, common ligand of multiple scavenger receptors) by RAW-FoxQ1 and RAW-vector clones, 
and found that both cell types showed similar rates of acLDL uptake (Fig. 4C).
FoxQ1 induces migration of RAW 264.7 cells towards MCP-1. Since FoxQ1 expression was found 
to be elevated in the circulating monocytes of patients with AD, the disease associated with accumulation of 
macrophages in skin lesions, we assessed another essential function of circulating monocytes – migration. The 
ability of FoxQ1 to stimulate migration towards key inflammatory chemotactic cytokine MCP-1 was investigated. 
MCP-1 is produced by keratinocytes, fibroblasts, macrophages, and other immune cells in sites of tissue inflam-
mation3,4, and instructs circulating monocytes to enter the lesion. In our study FoxQ1 significantly increased 
migration of RAW cells towards MCP-1 (p < 0.05) (Fig. 5A). Notably, all FoxQ1 clones uniformly increased their 
migratory ability towards MCP-1 (Fig. 5A).
Since MCP-1 had pronounced effect on migration of FoxQ1 expressing RAW cells, we tested whether FoxQ1 
stimulates expression of MCP-1 receptor CCR2, and found that there was a tendency for increased expression of 
CCR2 in RAW-FoxQ1 clones that did not reach statistical significance (Fig. 5B, p = 0.063, Mann-Whitney U test).
Our data indicated that FoxQ1 is crucial factor inducing migration of monocytes towards MCP-1. This finding 
also correlates with the fact, that recruitment of circulating monocytes is significantly increased in patients with 
AD2,21.
Identification of FoxQ1 inducible genes involved in monocyte migration. In order to identify 
FoxQ1-regulated genes that are involved in monocyte/macrophage migration, we compared five RAW 264.7 
clones expressing FoxQ1 and four empty vector clones using Affymetrix microarrays. The analysis of microarrays 
data revealed several clusters of differentially expressed genes involved in various biological processes including 
Figure 4. The analysis of inflammatory response and scavenging activity in FoxQ1 expressing RAW 264.7 
cells. (A) FoxQ1 and empty vector-transfected cells were stimulated with LPS for 3 h, 6 h and 24 h, and TNFα 
production was analyzed by ELISA. The data are mean ± SD for two vector and two FoxQ1 clones analyzed in 
triplicates. *p < 0.05, ***p < 0.001; One-way ANOVA with Sidak’s multiple comparison test. (B) Phagocytosis 
of fluorescent latex beads in FoxQ1 and vector clones was performed for 3 h and assessed using flow cytometry. 
The data are mean fluorescence intensity (MFI) ± SD for 3 independent experiments with 3 FoxQ1 and 3 empty 
vector clones, ns - not significant, two-tailed Student’s t test. (C) Endocytosis of acLDL-Alexa488 was performed 
for 30 min and measured using flow cytometry. The data are MFI ± SD for 3 independent experiments with 3 
FoxQ1 and 3 empty vector clones, ns - not significant, two-tailed Student’s t test.
Figure 5. The analysis of RAW 264.7-FoxQ1 migration towards MCP-1. (A) Migration of RAW 264.7 cells 
towards MCP-1 (100 ng/ml) was studied using Neuro Probe chemotaxis chamber. The data are combined for 5 
FoxQ1 and 5 vector-transfected clones and presented as mean ± SD. *p < 0.05, Kruskal-Wallis test with Dunn’s 
post-hoc test. (B) CCR2 expression was analyzed by RT-qPCR in 4 vector-transfected vs 5 FoxQ1 RAW 264.7 
clones. The data are presented as mean ± SD, p = 0.063, Mann-Whitney U test.
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cytoskeletal dynamics, migration and formation of tight junctions (Fig. 6A). Among them 21 genes responsible 
for cytoskeletal remodeling were upregulated in FoxQ1 expressing clones (Supplementary Table 1). In contrast, a 
cluster of 15 genes involved in the modulation of cellular migration and metastasis was downregulated in FoxQ1 
expressing clones (Supplementary Table 2). Validation of microarray data using RT-qPCR confirmed downreg-
ulation of the expression of Lsp1 (lymphocyte specific 1), Plxnc1 (plexin C1) and Cldn11 (claudin 11) genes 
known to play a role in cell migration23–26 (Fig. 6B). Next, we have examined whether expression of these genes 
is inhibited in human monocytes and macrophages under IL-4 stimulation. Lsp1 expression was not decreased 
in monocytes/macrophages stimulated with IL-4 for 3 h or 6 days suggesting regulation by other factors. The 
expression of claudin 11 was not detected in human primary monocytes and monocyte-derived macrophages. 
Of note, significant inhibition of plexin C1 expression was found in human monocytes stimulated with IL-4 for 
3 h (p < 0.05) and in monocyte-derived macrophages differentiated with IL-4 for 6 days (p < 0.01) suggesting 
that Plexin C1 repression is associated with increased FoxQ1 expression (Fig. 6C). However, there was no direct 
correlation between levels of FoxQ1 and Plexin C1 expression in the individual donors (data not shown) suggest-
ing that the magnitude of cellular response to FoxQ1 can be defined by the additional unknown factors, which 
expression or activity differs between macrophages from individual donors.
Discussion
The ability of macrophages to be rapidly re-polarized by changing cytokine milieu (i.e. macrophage plasticity) is 
widely reported19,27–29. On the molecular level re-polarization of macrophages with prototypic Th1/Th2 cytokines 
IFN-γ and IL-4 involves dynamic changes in expression of polarization markers such as CD206, arginase I, iNOS, 
chitinase-like proteins and others30–32. The results of our study extend the list of macrophage polarization markers 
and propose FoxQ1 as IL-4-responder gene that is tightly regulated by Th1/Th2 cytokine balance. In addition, 
FoxQ1 can serve as a potential biomarker of type 2 inflammation as discussed in our previous review33.
The accumulation of macrophages in skin lesions of AD patients is a known fact2,21. It was demonstrated that 
macrophage accumulation in skin lesions is increased with disease severity21. However, mechanisms related to 
monocyte recruitment in AD are insufficiently studied. Our study demonstrates that IL-4-driven factor FoxQ1 
is a crucial transcription factor responsible for increased monocyte migration. Thus, FoxQ1 is a candidate tran-
scription factor that can be responsible for increased monocyte influx in IL-4-related pathologies such as AD. 
Figure 6. FoxQ1 target genes are involved in monocyte migration. (A) RAW 264.7 clones stably expressing 
mouse FoxQ1 and empty vector clones were subjected to Affymetrix microarray analysis and clusters of 
differentially expressed genes related to multiple cellular functions were identified. (B) Differentially expressed 
genes responsible for cell migration (LSP1, Cldn11, Plxnc1) were verified in RAW 264.7 FoxQ1 clones using 
RT-qPCR. The data are mean ± SD for 5 FoxQ1 and 4 empty vector clones. **p < 0.01, ***p < 0.001, two-
tailed Student’s t-test. (C) The expression of plexin C1 was measured in monocytes of healthy donors (n = 4) 
stimulated with IL-4 for 3 h and in monocyte-derived macrophages (n = 4) stimulated with IL-4 for 6 days using 
RT-qPCR. The data are mean ± SD, *p < 0.05, **p < 0.01, two-tailed Student’s t-test.
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Indeed, we demonstrated that IL-4 induced expression of FoxQ1 in monocytes and monocyte-derived mac-
rophages. Moreover, its expression was significantly increased in monocytes of AD patients compared to healthy 
controls. Previous studies demonstrated that IL-4 was capable of inducing the expression of monocyte chemoat-
tractant MCP-1 in keratinocytes and its levels were elevated in AD patients21,34. Using RAW 264.7 monocyte/
macrophage cell line we showed that overexpression of FoxQ1 resulted in significant activation of monocyte 
migration towards MCP-1 gradient. On the gene expression level this was associated with downregulation of 
genes responsible for the control of cell migration (claudin 11 and plexin C1) as well as increase in expression 
of chemokine receptor CCR2. Thus, our data add on to previously published studies and suggest that IL-4 can 
induce migration of monocytes towards sites of chronic inflammation by simultaneous upregulation of FoxQ1 
in circulating monocytes and MCP-1 locally at the site of inflammation. Interestingly, Vogel et al. showed that 
IL-4 stimulated macrophages were characterized by enhanced velocity and migrated towards MCP-1 and other 
chemoattractants over longer distances and in a more organized fashion compared to non-stimulated and IFN-γ 
stimulated cells. Moreover, this migration pattern was associated with difference in cytoskeletal rearrangements 
in different subtypes of macrophages35. However, molecular factors responsible for increased macrophage motil-
ity in IL-4 stimulated cells were not examined. The results of our study suggest that acquisition of migratory phe-
notype in monocytes/macrophages is at least partially associated with IL-4-dependent induction of transcription 
factor FoxQ1 that affects expression of genes involved in cytoskeletal remodeling. Among them plexin C1 is 
responsible for inhibition of monocyte migration and is rapidly downregulated in IL-4 stimulated macrophages24. 
In addition, we have demonstrated that besides significant impact of FoxQ1 expression on monocyte migration 
it also accelerated TNFα production in response to pro-inflammatory stimuli which can potentially contribute 
to development of inflammatory disorders. Of note, it was previously reported that TNFα levels are increased in 
patients with AD and targeting this cytokine is one of therapeutic strategies in this disease36–38. TNFα is known 
to induce recruitment of cell types involved in pathogenesis of AD including eosinophils and CD4+ T cells39–43. 
In addition, TNFα induces activation of endothelial cells that facilitates adhesion and transmigration of mul-
tiple cell types in the area of inflammation44–47. Interestingly, in a recent study hepatocellular carcinoma cells 
expressing FoxQ1 were shown to increase recruitment of macrophages through CCL2 production. Macrophage 
depletion in FoxQ1 expressing tumors resulted in significant decrease in TNFα expression48. This data partially 
corresponded to our results. However, study by Xia et al. focused on FoxQ1 expression in tumor cells and did not 
take into consideration eventual expression of FoxQ1 in tumor macrophages. Overall, our data identify FoxQ1 as 
a novel IL-4-induced transcription factor in macrophages that facilitates their migration in chronic inflammatory 
conditions.
Materials and Methods
Atopic dermatitis patients. Eight patients (18–60 years old) with clinically proven atopic dermatitis and 
high serum IgE levels were involved in the study. All biological material has been collected, processed and han-
dled in accordance with the German legislation on bioethics (approval by the Mannheim Ethics Committee of 
the Medical Faculty Mannheim, University of Heidelberg, approval number 112/05) and informed consent was 
obtained from all patients.
Primary macrophages and cell lines. Human peripheral blood mononuclear cells were isolated and cul-
tivated as described49. Briefly, the cells were purified from individual buffy coats by sequential density gradient 
centrifugations followed by CD14+ magnetic cell sorting (Miltenyi Biotech). Macrophages were cultivated in 
X-VIVO 10 Serum-free medium (Cambrex) at a concentration of 1 × 106 cells/ml. The cells were stimulated with 
10 ng/ml IL-4 and 100 ng/ml IFN-γ (both from Peprotech) as indicated. The detailed protocol for monocyte iso-
lation is available online (http://www.methods.info/).
Human colorectal cancer cell line WIDR was kindly provided by research group of Prof. Heike Allgayer 
(Medical Faculty Mannheim, University of Heidelberg) and cultured in McCoys medium (Gibco) supplemented 
with 10% FBS (Biochrom). RAW 264.7 cells (ATCC CRL-6323) were obtained from American Type Culture 
Collection and grown in Dulbecco’s modified Eagle’s medium (DMEM) containing 10% FCS, 1% non-essential 
amino acids, 1% penicillin/streptomycin and 1% sodium pyruvate.
For the generation of RAW 264.7 cell lines stably expressing FoxQ1, the DNA fragment encoding murine 
FoxQ1 was amplified using High Fidelity PCR (Roche) and plasmid pCMV-SPORT6-mouse FoxQ1 (ImaGenes) 
as a template and primers mFoxQ1-NotI-fw 5′3′ and mFoxQ1-BamHI-rv: 5′3′. Further, mFoxQ1 fragment was 
subcloned into the expression vector pEF6/V5-His Topo (Invitrogen) using NotI and BamHI restriction sites 
followed by sequencing of the final product. The pEF6/V5-His mFoxQ1 expression construct was transfected in 
RAW264.7 cells using Nucleofector Kit V and Nucleofector Device (Lonza). Single-cell derived stable clones were 
selected using blasticidin S (Invitrogen) at the concentration of 6 µg/ml. Stable expression of FoxQ1 was detected 
by immunofluorescent analysis using anti-V5 ab (Invitrogen). As a negative control, RAW 264.7 were stably 
transfected with pEF6/V5-His Topo vector.
RNA isolation and cDNA synthesis. Isolation of total RNA from cells was performed using E.Z.N.A. 
total RNA Kit I (Omega bio-tek) according to manufacturer’s recommendation. For cDNA synthesis RevertAid 
H Minus First Strand Synthesis Kit (Fermentas) was used. Prior to cDNA synthesis 0.5 µg RNA were treated with 
2 U DNAse I (Fermentas).
Microarray analysis. For oligonucleotide microarray analysis, total RNA was isolated out of five FoxQ1 and 
four empty vector RAW 264.7 clones and hybridized on GeneChip Mouse Genome 430 2.0 Array (Affymetrix). 
The data were submitted to GEO database, accession number of the study is GSE79521. cDNA and cRNA syn-
thesis and hybridization to arrays were performed according to the recommendations of the manufacturer. A 
www.nature.com/scientificreports/
7SCIENTIFIC RepoRts | 7: 16847  | DOI:10.1038/s41598-017-17307-z
Custom CDF Version 12 with Entrez based gene definitions was used to annotate the arrays. The raw fluorescence 
intensity values were normalized applying quantile normalization. Differential gene expression was analysed 
based on One-Way ANOVA, using a commercial software package SAS JMP7 Genomics, version 4, from SAS 
(SAS Institute, Cary, NC, USA). A false positive rate of a = 0.05 with FDR correction was taken as the level of 
significance.
RT-qPCR analysis. RT-qPCR analysis was performed to identify relative quantification of gene expres-
sion. SybrGreen-based identification of relative gene expression of mouse Cldn11, Lsp1, and Plxnc1 was per-
formed using SensiMixTM SYBR Low-ROX One-Step Kit (company). The expression of human FOXQ1, mouse 
Foxq1, human CLDN11, LSP1, and PLXNC1 was assessed using Taqman dual-labeled probes and TaqMan Gene 
Expression Master Mix (Applied Biosystems). Mouse Ccr2 was amplified using predesigned TaqMan CCR2 assay 
(Life technologies). Normalization of gene expression levels was performed using housekeeping genes GAPDH 
or Actb. All oligonucleotides used in the present study were from MWG-Biotech and are listed in Supplementary 
Table 3.
Immunofluorescence and confocal microscopy. Cells were fixed as described previously50. RAW 
264.7 cells were stained using anti-V5 antibodies (Invitrogen, cat R960-25) followed by Cy3-conjugated donkey 
anti-mouse IgG (Dianova). Primary human macrophages and WIDR colorectal cancer cells were stained using 
goat anti-human FoxQ1 antibody (clone C-16, Santa Cruz Biotechnology) followed by Cy3-conjugated donkey 
anti-goat IgG (Dianova). Nuclei were visualized using DRAQ5 (Cell Signaling Technology). Leica TCS SP2 and 
Leica TCS SP8 laser-scanning spectral confocal microscopes equipped with a 63x objective were used for confocal 
laser-scanning microscopy. Data were acquired and analyzed with Leica Confocal software. All multicolor images 
were acquired and assembled using a sequential scan mode.
Phagocytosis and endocytosis assays. For the quantification of the uptake of phagocytic and endocytic 
ligands, RAW-FoxQ1 cells and RAW-vector cells were plated in 12-well plates in concentration 5 × 105 cells per 
well. After 18 h, 1 µm size green fluorescent latex beads (Polysciences, Inc.) were added at 50 particles per cell. 
Incubation with beads was performed at 37 °C for 3 h. For endocytosis acLDL-Alexa488 (Molecular Probes) has 
been added to cells at the concentration of 5 µg/ml and incubated at 37 °C for 30 min. All incubations were per-
formed in triplicates within one experiment, and 3 independent experiments have been conducted. Uptake of 
fluorescently-labeled ligands was quantified by flow cytometry using FACS CantoII.
LPS-induced TNFα production assay. For TNFα secretion assay two RAW FoxQ1 clones with the high-
est level of FoxQ1 expression and two RAW-vector clones were plated in a 24-well plate (5 × 105 cells per well 
for 24 h and 1 × 106 cells per well for 3 and 6 h time point) and stimulated with 1 µg/ml LPS. TNFα level in 
supernatants was determined by mouse TNFα DuoSet ELISA Kit (R&D systems) according to manufacturer’s 
recommendation.
Cell migration assay. A forty-eight-well microchemotaxis chamber (Neuroprobe) and a polycarbonate filter 
with 8 µm pore size were used. The cells were added to the chamber (3 × 104 cells/well) and allowed to migrate 
towards MCP-1 (R&D Systems) at the concentration of 100 ng/ml. After 2 h incubation at 37 °C and 5% CO2, the 
cells that had not migrated and remained on the upper side of membrane were removed by scraping. The cells 
that migrated and were located on the down-side of membrane were fixed with 4% paraformaldehyde (Fluka). 
Fixed membranes were stained with cell stain solution (Cell Biolabs, Inc.). Migrated cells were counted in 3 
randomly selected fields per well under the microscope using 10x magnification. Five RAW-mFoxQ1 clones and 
five RAW-empty vector clones were compared in triplicates (three wells per clone). The experiment was repeated 
three times.
Statistical analysis. The difference between experimental groups was analyzed using two-tailed Student’s 
t-test, Mann- Whitney U test, ANOVA with Tukey’s and Sidak’s post-hoc tests, or Kruskal-Wallis test with Dunn’s 
post-hoc test as indicated in the text and figure legends. The difference was considered statistically significant at 
p < 0.05 level.
Data availability. The datasets generated during and/or analyzed during the current study are available from 
the corresponding author on reasonable request.
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